Physician profile
Norman E Gotlieb
NPI 1124010590
$9,404.33
in general payments reported to CMS, 2019-2025
43 companies · $1,410 in 2025
The $1,410 reported for 2025 was more than what 77% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,433 · 2020: $609 · 2021: $753 · 2022: $1,803 · 2023: $2,021 · 2024: $1,375 · 2025: $1,410.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,806.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,806.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,678.37 | 2019-2025 | Jot Dx, Aveir, Confirm Rx |
| Novartis Pharmaceuticals Corporation | $1,072.07 | 2019-2025 | |
| Amgen INC. | $870.03 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $694.49 | 2020-2025 | |
| Philips North America LLC | $563.57 | 2020-2025 | Ambulatory Monitoring & Diagnostics Undivided, (Cm9) Amb Mon & Diag Und, (5091) Amb Mon & Diag Und |
| Boehringer Ingelheim Pharmaceuticals, INC. | $494.38 | 2020-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $473.61 | 2019-2025 | Camzyos, Eliquis |
| Astellas Pharma US INC | $449.24 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $386.47 | 2019-2025 | Farxiga, Wainua |
| Janssen Pharmaceuticals, INC | $346.08 | 2019-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $281.30 | 2021-2023 | Verquvo |
| Atricure, INC. | $181.32 | 2019-2023 | |
| Boston Scientific Corporation | $156.17 | 2021-2025 | Lux-Dx Insertable Cardiac Monitor, General - Structural Heart, Watchman Flx |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $155.20 | 2019-2024 | Lifevest |
| Heartflow, INC. | $145.43 | 2022-2024 |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $113.89 | 2023-2025 | |
| Kestra Medical Technology Services, INC. | $106.55 | 2023-2024 | Assure Wcd |
| Amarin Pharma, INC. | $95.52 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $92.76 | 2019-2024 | |
| Esperion Therapeutics, INC. | $83.79 | 2024-2025 | Nexletol |
| Kiniksa Pharmaceuticals International, Plc | $76.83 | 2024 | Arcalyst |
| Bridgebio Pharma, INC. | $74.46 | 2025 | Attruby |
| Novo Nordisk INC | $74.29 | 2025 | Ozempic |
| Kowa Pharmaceuticals America, INC. | $71.43 | 2019-2023 | Livalo |
| Kiniksa Pharmaceuticals, LTD. | $71.29 | 2022 | |
| Biosense Webster, INC. | $70.60 | 2022 | |
| Alnylam Pharmaceuticals INC. | $65.55 | 2024-2025 | Onpattro |
| Regeneron Healthcare Solutions, INC. | $63.72 | 2019 | |
| Medtronic, INC. | $51.91 | 2021-2023 | Micra |
| Cleerly, INC. | $46.26 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Medtronic Vascular, INC. | $44.95 | 2019 | |
| Lilly USA, LLC | $42.58 | 2025 | Zepbound, Mounjaro |
| Abiomed | $30.95 | 2024 | Impella |
| Cardiva Medical, INC. | $29.08 | 2022 | |
| Agepha Pharma Fz LLC | $24.66 | 2024 | Lodoco |
| Cvrx, INC. | $20.06 | 2024 | Barostim Neo System |
| Surmodics, INC. | $19.48 | 2025 | Sublime Microcatheter, 018, 200cm, Straight, Pounce Venous Thrombectomy System, Pounce Thrombectomy System |
| Akcea Therapeutics, INC. | $16.36 | 2020 | |
| Chiesi USA, INC. | $15.89 | 2022 | |
| Arbor Pharmaceuticals, INC. | $15.15 | 2019 | |
| Preventice Services, LLC | $13.53 | 2021 | |
| Shockwave Medical, INC | $12.70 | 2022 | |
| G Medical Diagnostic Services, INC. | $12.36 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Norman Gotlieb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.